For newly diagnosed adults whose kidney cancer (renal cell carcinoma) has spread
OPDIVO® (nivolumab) is a prescription medicine used in combination with cabozantinib to treat people with kidney cancer when your cancer has spread (advanced renal cell carcinoma) and you have not already had treatment for your advanced RCC. Please read the Patient Information that comes with cabozantinib.
It is not known if OPDIVO is safe and effective in children younger than 18 years of age.
In a clinical trial of 651 KIDNEY CANCER
323 patients were
given OPDIVO +
328 patients were given SUTENT® (sunitinib malate), a standard treatment
PATIENTS LIVED 2X LONGER WITHOUT CANCER PROGRESSING*
*Spreading, growing, or getting worse.
Half of patients on OPDIVO + CABOMETYX went 16.6 months without cancer growing, spreading, or getting worse.
Half of patients on SUTENT went 8.3 months without cancer growing, spreading, or getting worse.
OPDIVO + CABOMETYX reduced the risk of cancer spreading, growing, or getting worse by 49% compared to SUTENT alone.
OPDIVO will not work for everyone. Individual results may vary.See additional clinical trial
ADDITIONAL RESOURCES FOR PATIENTS AND CAREGIVERS
View additional materials you or your loved one may find helpful, including information on support materials, questions to ask your doctor, and other patient resources.
SIGN UP FOR
Complimentary support, tools,
and educational resources for anyone
considering or currently taking OPDIVO.
or click to learn more.
HAVE YOU DOWNLOADED OUR
PATIENT BROCHURE YET?
Find out how OPDIVO,
in combination with CABOMETYX,
works to treat kidney cancer
(renal cell carcinoma) that has spread
For information regarding CABOMETYX, call 1-844-900-EASE (1-844-900-3273) or visit cabometyx.com
Important Facts About OPDIVO®
OPDIVO can cause problems that can sometimes become serious or life-threatening and can lead to death. Serious side effects may include lung problems; intestinal problems; liver problems; hormone gland problems; kidney problems; skin problems; problems in other organs and tissues; severe infusion reactions; and complications of stem cell transplant that uses donor stem cells (allogeneic). Call or see your healthcare provider right away for any new or worsening signs or symptoms.
Important Facts About OPDIVO® (nivolumab)
This is a summary of important information that you need to know about OPDIVO. Your healthcare team can work with you to help answer any questions you may have about these medications. Keep this information in a safe place so you can refer to it before and during your treatment.
Look out for the following
icons as you read:
- Talk to your
- Call a healthcare
provider right away
- Helpful information
OPDIVO is a prescription medicine used in combination with cabozantinib for people:
Whose kidney cancer has spread (advanced RCC) AND
Who have not already had treatment for their advanced RCC.
Please read the Patient Information that comes with cabozantinib.
It is not known if OPDIVO is safe and effective in children younger than 18 years of age.
OPDIVO (10 mg/mL) is an injection for intravenous (IV) use.
OPDIVO is a medicine that may treat certain cancers by working with your immune system. OPDIVO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. Some of these problems may happen more often when OPDIVO is used in combination with another therapy.
Get medical help immediately if you develop any of these signs or symptoms or they get worse. It may keep these problems from becoming more serious. Your healthcare team will check you for these problems during treatment and may treat you with corticosteroid or hormone replacement medicines. If you have severe side effects, your healthcare team may also need to delay or completely stop your treatment.
A serious side effect is a side effect that can sometimes become severe or life-threatening and can lead to death. They may happen anytime during treatment or even after your treatment has ended. You may have more than one of these problems at the same time.
Call or see your healthcare provider right away if you develop any new or worse signs or symptoms, including:
Lung problems — Things to look out for may include:
- new or worsening cough
- shortness of breath
- chest pain
Intestinal problems — Things to look out for may include:
- diarrhea (loose stools) or more
bowel movements than usual
- stools that are black, tarry, sticky, or have blood or mucus
- severe stomach-area (abdominal) pain or tenderness
Liver problems — Things to look out for may include:
- yellowing of your skin or
the whites of your eyes
- severe nausea or vomiting
- pain on the right side of your
stomach area (abdomen)
- dark urine (tea colored)
- bleeding or bruising more easily
Hormone gland problems — Things to look out for may include:
- headaches that will not go away
or unusual headaches
- eye sensitivity to light
- eye problems
- rapid heartbeat
- increased sweating
- extreme tiredness
- weight gain or weight loss
- feeling more hungry or thirsty than usual
- urinating more often than usual
- hair loss
- feeling cold
- your voice gets deeper
- dizziness or fainting
- changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness
Kidney problems — Things to look out for may include:
- decrease in the amount of urine
- blood in your urine
- swelling in your ankles
- loss of appetite
Skin problems — Things to look out for may include:
- skin blistering or peeling
- painful sores or ulcers in the mouth or nose, throat, or genital area
Problems can also happen in other organs and tissues. These are not all the signs and symptoms of immune system problems that can happen with OPDIVO. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include:
- Chest pain, irregular heartbeat, shortness of breath, swelling of ankles
- Confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs
- Double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight
- Persistent or severe muscle pain or weakness, muscle cramps
- low red blood cells, bruising
OPDIVO can cause serious side effects, including:
See the previous section, “What is the most important information I should know about OPDIVO?”
Severe infusion reactions — Things to look out for may include:
- chills or shaking
- itching or rash
- shortness of breath or wheezing
- feel like passing out
- back or neck pain
Tell your healthcare team right away if you get these symptoms during an infusion of OPDIVO.
Complications of bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be severe and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with OPDIVO. Your healthcare provider will monitor you for these complications.
The most common side effects of OPDIVO when used in combination with cabozantinib include:
- feeling tired or weak
- liver problems
- rash, redness, pain, swelling or blisters on the palms of your hands or soles of your feet
- mouth sores
- high blood pressure
- low thyroid hormone levels
- pain in muscles, bones, and joints
- decreased appetite
- change in the sense of taste
- stomach-area (abdominal) pain
- upper respiratory tract infection
These are not all of the possible side effects. Talk to your healthcare team or pharmacist for more information. You are encouraged to report side effects of prescription drugs to the FDA. Call 1-800-FDA-10881-800-FDA-1088.
Tell your healthcare provider about all your medical conditions, including if you:
- have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus
- have received an organ transplant
- have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
- have received radiation treatment to your chest area in the past and have received other medicines that are like OPDIVO
- have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome
- are pregnant or plan to become pregnant. OPDIVO can harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if OPDIVO passes into your breast milk. Do not breastfeed during treatment with OPDIVO and for 5 months after the last dose of OPDIVO.
Females who are able to become pregnant:
Your healthcare provider should do a pregnancy test before you start receiving OPDIVO.
- You should use an effective method of birth control during your treatment and for at least 5 months after the last dose of OPDIVO. Talk to your healthcare provider about birth control methods that you can use during this time.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with OPDIVO.
Tell your healthcare provider about all the medicines you take, including:
- prescription medicines
- over-the-counter medicines
- herbal supplements
For more information, please see accompanying U.S. Full Prescribing Information and Medication Guide for OPDIVO, or talk to your healthcare team.